Your browser doesn't support javascript.
loading
Phase I study of anti-epidermal growth factor receptor antibody-drug conjugate serclutamab talirine: Safety, pharmacokinetics, and antitumor activity in advanced glioblastoma.
Carneiro, Benedito A; Papadopoulos, Kyriakos P; Strickler, John H; Lassman, Andrew B; Waqar, Saiama N; Chae, Young Kwang; Patel, Jyoti D; Shacham-Shmueli, Einat; Kelly, Karen; Khasraw, Mustafa; Bestvina, Christine M; Merrell, Ryan; Huang, Kevin; Atluri, Harisha; Ansell, Peter; Li, Rachel; Jin, Janet; Anderson, Mark G; Reilly, Edward B; Morrison-Thiele, Gladys; Patel, Kalpesh; Robinson, Randy R; Aristide, Martha R Neagu; Gan, Hui K.
Afiliação
  • Carneiro BA; Legorreta Cancer Center at Brown University, Providence, Rhode Island, USA.
  • Papadopoulos KP; Lifespan Cancer Institute, Providence, Rhode Island, USA.
  • Strickler JH; START San Antonio, San Antonio, Texas, USA.
  • Lassman AB; Division of Medical Oncology, Duke University Medical Center, Durham, North Carolina, USA.
  • Waqar SN; Division of Neuro-Oncology, Department of Neurology, Columbia University Vagelos College of Physicians and Surgeons, the Herbert Irving Comprehensive Cancer Center, New York, New York, USA.
  • Chae YK; New York-Presbyterian Hospital, New York, New York, USA.
  • Patel JD; Division of Oncology, Department of Medicine, Washington University School of Medicine, St. Louis, Missouri, USA.
  • Shacham-Shmueli E; Feinberg School of Medicine, Northwestern University, Chicago, Illinois, USA.
  • Kelly K; Robert H. Lurie Comprehensive Cancer Center of Northwestern University, Chicago, Illinois, USA.
  • Khasraw M; Department of Oncology, Sheba Medical Center, Ramat Gan, Israel.
  • Bestvina CM; University of California Davis Comprehensive Cancer Center, Sacramento, California, USA.
  • Merrell R; The Preston Robert Tisch Brain Tumor Center, Duke University, Durham, North Carolina, USA.
  • Huang K; The University of Chicago Medicine, Chicago, Illinois, USA.
  • Atluri H; Department of Neurology, NorthShore University Health System, Evanston, Illinois, USA.
  • Ansell P; AbbVie Inc., North Chicago, Illinois, USA.
  • Li R; AbbVie Inc., North Chicago, Illinois, USA.
  • Jin J; AbbVie Inc., North Chicago, Illinois, USA.
  • Anderson MG; AbbVie Inc., North Chicago, Illinois, USA.
  • Reilly EB; AbbVie Inc., North Chicago, Illinois, USA.
  • Morrison-Thiele G; AbbVie Inc., North Chicago, Illinois, USA.
  • Patel K; AbbVie Inc., North Chicago, Illinois, USA.
  • Robinson RR; AbbVie Inc., North Chicago, Illinois, USA.
  • Aristide MRN; AbbVie Inc., North Chicago, Illinois, USA.
  • Gan HK; AbbVie Inc., South San Francisco, California, USA.
Neurooncol Adv ; 5(1): vdac183, 2023.
Article em En | MEDLINE | ID: mdl-36814898
Palavras-chave
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Idioma: En Ano de publicação: 2023 Tipo de documento: Article
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Idioma: En Ano de publicação: 2023 Tipo de documento: Article